Superworth

Mesa Laboratories revenue MLAB

Sales by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
$249.7M
Latest quarter, Q1 FY27
$60.1M
+1% on a year earlier
Fiscal year 2026
$249.1M
+3% on the year before

Mesa Laboratories' revenue was $249.7M over the twelve months to Jun 30, 2026, up 3% on a year earlier.

In its latest quarter, Q1 FY27, it was $60.1M, up 1% on the same quarter a year before.

Over the five fiscal years to FY2026 it grew 13% a year on average.

Revenue over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearRevenueChange
FY2026$249.1M+3%
FY2025$241M+11%
FY2024$216.2M−1%
FY2023$219.1M+19%
FY2022$184.3M+38%
FY2021$133.9M+14%
FY2020$117.7M+14%
FY2019$103.1M+7%
FY2018$96.2M+3%
FY2017$93.7M+11%
FY2016$84.7M+19%
FY2015$71.3M+35%
FY2014$52.7M+14%
FY2013$46.4M+17%
FY2012$39.6M+16%

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedRevenueOn a year earlierLast 12 months
Q1 FY27$60.1M+1%$249.7M
Q4 FY26$63.7M+3%$249.1M
Q3 FY26$65.1M+4%$247.5M
Q2 FY26$60.7M+5%$245.3M
Q1 FY26$59.5M+2%$242.4M
Q4 FY25$62.1M+5%$241M
Q3 FY25$62.8M+18%$237.7M
Q2 FY25$57.8M+9%$228.4M
Q1 FY25$58.2M+15%$223.7M
Q4 FY24$58.9M+6%$216.2M
Q3 FY24$53.5M−1%$212.9M
Q2 FY24$53.2M−10%$213.7M

Against its peers

Companies in Hardware, Equipment & Parts nearest Mesa Laboratories' size, closest first, today.

CompanyRevenue, 12 monthsGrowth
MLABMesa Laboratories$249.7M+3% a year
FEIMFrequency Electronics$72.9M+6% a year
VPGVishay Precision$328.6M+11% a year
TRNSTranscat$348.4M+21% a year
VREXVarex Imaging$865M+5% a year
KEKimball Electronics$1.4B−4% a year
ALNTAllient$574.8M+11% a year
CTSCTS$564.3M+9% a year
MPTIM-tron Industries$58.2M+12% a year
BHEBenchmark Electronics$2.8B+9% a year
INTTIntest$128.3M+5% a year
Peer median$456.3M

Where Mesa Laboratories ranks

What the revenue tells you

Total sales in the period. On the company page, quarterly bars or the trailing twelve months (TTM), which smooths seasonality.

Growing revenue with shrinking margins is a warning, not a win.

More on Mesa Laboratories

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.